An evaluation of the DDAVP infusion test with PFA-100 and vWF activity assays to distinguish vWD types in children

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 5, 2011, Pages 441-448

  Akin, Mehmet ^a   Karapinar, Deniz Yilmaz ^a   Balkan, Can ^a   Ay, Yilmaz ^a   Kavakli, Kaan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

DDAVP; PFA 100; von Willebrand disease (vWD); von Willebrand factor (vWF)

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; RISTOCETIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ANALYZER; ARTICLE; BLEEDING; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC ANALYSIS; HUMAN; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; PLATELET FUNCTION ANALYZER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; THROMBOCYTE AGGREGATION; VON WILLEBRAND DISEASE;

BLOOD COAGULATION TESTS; CHILD; CHILD, PRESCHOOL; DEAMINO ARGININE VASOPRESSIN; FACTOR VIII; FEMALE; HEMOSTATICS; HUMANS; INFANT; MALE; PLATELET FUNCTION TESTS; VON WILLEBRAND DISEASE, TYPE 1; VON WILLEBRAND DISEASE, TYPE 2; VON WILLEBRAND DISEASE, TYPE 3; VON WILLEBRAND FACTOR;

EID: 80053605263     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029610366440     Document Type: Article

References (31)

1. Favaloro EJ, Facey D, Grispo L. Laboratory assessment of Von Willebrand factor: use of different assays can influence the diagnosis of Von Willebrand's disease, depending on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms. Am J Clin Pathol. 1995 ; 104 (3). 264-271
2. Favaloro EJ, Bonar R, Sioufi J, et al. Laboratory diagnosis of Von Willebrand disorder. Current practice in the southern hemisphere. Am J Clin Pathol. 2003 ; 119 (6). 882-893 (Pubitemid 37047851)
3. Cattaneo M, Federici AB, Lecchi A, et al. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with Von Willebrand disease. Thromb Haemost. 1999 ; 82 (1). 35-39 (Pubitemid 29368770)
4. Favaloro EJ, Kershaw G, Bukuya M, Hertzberg M, Koutts J. Laboratory diagnosis of Von Willebrand Disorder (VWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and VWF:CBA as combined diagnostic strategies. Haemophilia. 2001 ; 7 (2). 180-189 (Pubitemid 32243801)
5. Sadler EJ. A revised classification of Von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 1994 ; 71 (4). 520-525
6. Sadler JE, Budde U, Eikenboom JCJ, et al. Update on the pathophysiology and classification of Von Willebrand disease: a report of the Subcommittee on Von Willebrand Factor. J Thromb Haemost. 2006 ; 4 (10). 2103-2114 (Pubitemid 44403432)
7. Sadler JE, Mannucci PM, Bentorp E, et al. Impact,diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000 ; 84 (2). 160-174 (Pubitemid 30601459)
8. Michiels JJ, van de Velde A, van Vliet HHDM, van der Planken M, Schroyens W, Berneman Z. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications. Semin Thromb Hemost. 2002 ; 28 (2). 111-131 (Pubitemid 34439202)
9. Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van Vliet HHDM. Laboratory Diagnosis and Molecular Basis of Mild von Willebrand Disease Type 1. Acta Haematol. 2009 ; 121 (2-3). 85-97
10. Tosetto A, Rodeghiero F, Castaman G, et al. A quantitative analysis of bleeding symptoms in type 1 Von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost. 2006 ; 4 (4). 766-773
11. Favaloro EJ. Laboratory identification of Von Willebrand Disease: technical and scientific perspectives. Semin Thromb Hemost. 2006 ; 32 (5). 456-471 (Pubitemid 44157383)
12. Nichols WL, Hultin MB, James AH, et al. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008 ; 14 (2). 171-232 (Pubitemid 351343618)
13. Schneppenheim R, Budde U. Phenotypic and genotypic diagnosis of Von Willebrand disease: a 2004 update. Semin Hematol. 2005 ; 42 (1). 15-28 (Pubitemid 40127266)
14. Michiels JJ, Gadisseur A, Budde U, et al. Characterization, classification, and treatment of Von Willebrand disease: a critical appraisal of the literature and personal experiences. Semin Thromb Hemost. 2005 ; 31 (5). 577-601 (Pubitemid 41642572)
15. Favaloro EJ. The utility of the PFA-100 in identification of Von Willebrand Disease: a concise review. Semin. Thromb Hemost. 2006 ; 32 (5). 537-545 (Pubitemid 44157393)
16. Roschitz B, Thaller S, Koestenberger M, et al. PFA-100 closure times in preoperative screening in 500 pediatric patients. Thromb Haemost. 2007 ; 98 (1). 243-247 (Pubitemid 47074202)
17. Kerenyi A, Schlammadinger A, Ajzner E, et al. Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function. Thromb Res. 1999 ; 96 (6). 487-492
18. Schlammadinger A, Kerenyi A, Muszbek L, Boda Z. Comparison of the O'Brien filter test and the PFA-100 platelet analyser in the laboratory diagnosis of Von Willebrand's disease. Thromb Haemost. 2000 ; 84 (1). 88-92 (Pubitemid 30433674)
19. Favaloro EJ, Lillicrap D, Lazzari MA, et al. Laboratory aspects of diagnosis and treatment. Haemophilia. 2004 ; 10 (suppl 4). 164-168
20. Goodeve A, Eikenboom J, Castaman G, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 Von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 Von Willebrand disease (MCMDM-1VWD). Blood. 2007 ; 109 (1). 112-121 (Pubitemid 46053051)
21. Lanke E, Johansson AM, Halldén C, Lethagen S. Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype. J Thromb Haemost. 2005 ; 3 (12). 2656-2663 (Pubitemid 41819792)
22. Michiels JJ, Berneman Z, Gadisseur A, et al. Characterization of recessive severe type 1 and 3 Von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related Von Willebrand factor deficiency, and dominant type 1 VWD. Clin Appl Thromb Hemost. 2006 ; 12 (3). 277-295 (Pubitemid 44400839)
23. Budde U, Schneppenheim R, Plendl H, Dent J, Ruggeri ZM, Zimmerman TS. Luminographic detection of Von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost. 1990 ; 63 (2). 312-315 (Pubitemid 20128202)
24. Eikenboom J, Van Marion V, Putter H, et al. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost. 2006 ; 4 (4). 774-782
25. Woods AI, Blanco AN, Chuit R, et al. Major haemorrhage related to surgery in patients with type 1 and possible type 1 von Willebrand disease. Thromb Haemost. 2008 ; 100 (5). 797-802
26. Van Vliet HHDM, Kappers-Klunne MC, Leebeek F, Michiels JJ. PFA-100 monitoring of von Willebrand factor (VWF) responses to DDAVP and FVIII/VWF concentrate in von Willebrand disease type 1 and 2. Thromb Haemost. 2008 ; 100 (3). 462-468
27. Favaloro EJ. A better approach to monitoring of therapy in von Willebrand disease?. Thromb Haemost. 2008 ; 100 (3). 371-373
28. Millar CM, Riddell AF, Brown SA, et al. Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycolysation, proteolysis and gene mutations. Thromb Haemost. 2008 ; 99 (5). 916-924 (Pubitemid 351705309)
29. Budde U, Schneppenheim R, Eikenboom J, et al. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost. 2008 ; 6 (5). 762-771 (Pubitemid 351524536)
30. Veyradier A, Fressinaud E, Boyer-Neumann C, Trossaert M, Meyer D. von Willebrand factor ristocetin cofactor activity correlates with platelet function in a high shear stress system. Thromb Haemost. 2000 ; 84 (4). 727-728
31. Favaloro EJ, Bonar R, Meiring M, Street A, Marsden K. RCPA QAP in Haematology. 2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of type 2B VWD. Thromb Haemost. 2007 ; 98 (2). 346-358 (Pubitemid 47250238)